These pieces of evidence indicate that PAR2 in psoriasis exhibits diverse effects depending on its location in different cell types-lower expression in keratinocytes versus higher expression in mast cells and enhanced epidermal expression of PAR2 in scalp-indicating a closely correlated pathophysiology involving multiple cell variants in the cutaneous microenvironment. This evidence concerns the gene F2RL1 and psoriasis.